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The antiproteolytic activity of serum, and its changes in association with 
disease are little understood in spite of the extensive work that has been done 
in this field. The increase in inhibition by serum during various disease states 
has been repeatedly studied since the original observation of Ascoli and Bezzola 
in  1903 (1)  (reviews,  2,  3).  Trypsin has been  the enzyme usually employed 
in these studies. Variation in the inhibition of plasmin and chymotrypsin with 
disease has not received so much attention. 
There  have  been  no previous  reports  of changes  in  an  accurately meas- 
urable biological phenomenon occurring consistently with changes in proteo- 
• lyric inhibition. Therefore it has been difficult to relate changes in proteolytic 
inhibition to other biological phenomena. In the work to be presented, normal 
and pathological variations in proteolytic inhibition were analyzed. The re- 
lationship between proteolytic inhibition and other biological measurements 
was studied in an attempt to gain information concerning the  significance of 
changes in proteolytie inhibition. 
Materials and Methods 
Patients.---Observations  on patients  with neoplastic  diseases were made on the medical 
and surgical services at Memorial Hospital and James Ewing Hospital. Patients with various 
other  diseases  were studied  by  permission  of the  Department  of Medicine at  New  York 
Hospital and by permission of the Columbia Medical Division at Bellevue Hospital. Measure- 
ments of proteolytic inhibition were done on blood samples taken on the day of admission 
to the hospital, prior to the start  of treatment.  However, a  number of patients with lym- 
phoma or leukemia  had received x-ray therapy in the course of their illness  prior to admis- 
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sion to the hospital, and most of the patients with tuberculosis had received some form of 
treatment. 
Serum protedyt6; inhibition of 65 normal individuals and of 117 patients was measured as 
described in Paper II and the determinations are shown in Figs. 1 to 3 of Paper II. Other 
measurements of serum proteolytic inhibition in the present paper were also done by the 
method described in Paper II. 
Sedimentation rate was determined by the method of Wintrobe and Landsberg (4). 
Plasma fibrinogen was separated as fibrin by the clotting method of Cullen and Van Slyke 
(5), and nitrogen determination was done by the micro-Kjeldahl method. The determina- 
tion on each sample was done in duplicate and averaged. 
Typhdd  vavdne was a preparation obtained from Lederle Laboratories called typhoid- 
paratyphoid vaccine  for non-specific  protein therapy. 1 cc. contained 100 ×  106 killed bacteria. 
RESULTS 
Variation in Proteolytic Inhibition in Normal Individuals 
The  variation  in  inhibition  of plasmin,  trypsin,  and  chymotrypsin in  65 
normal adult individuals was shown in Figs.  1 to 3 of Paper II. For plasmin 
the 2 sigma variation was 44 per cent of the mean, for trypsin it was 64 per 
cent,  and  for  chymotrypsin it  was  34 per  cent.  This  observed variation  in 
normal  sera  was  not  due  to  experimental  error .alone,  since  the  variation 
found when a  single normal serum was run 15 times (i.e., experimental error) 
was much less  than the  variation  found  among different  normal  sera. With 
plasmin the 2 sigma variation was 20 per cent of the mean and with trypsin 
it was 28 per cent. 
Approximately two-thirds of the subjects in the group of 65  normal  indi- 
viduals were male and one-third were female; approximately two-thirds were 
fasting,  and  one-third  had  eaten  within  4  hours  of  the  determination.  For 
each enzylne, there was no difference in the mean value of inhibition between 
males  and  females  or between  fasting  and  non-fasting subjects.  The  varia- 
tions of inhibition  within  the normal range did not appear  to be related  to 
sex or the recentness of food ingestion. 
When inhibition of plasmin and trypsin was determined for one male indi- 
vidual at frequent intervals over a  period of several months, the variation in 
inhibition  was no greater  than  that for repeated  determinations on a  single 
serum sample. The serum inhibition of plasmin and trypsin was constant for 
any one individual over a  long period of time. 
Correlation  of Clinical Data with Abnormal Proteolytic Inhibition 
It was shown in Paper II that a  large percentage of patients With  cancer, 
various acute diseases,  and  tuberculosis had  increased inhibition  for trypsin 
and  chymotrypsin, while  few had  increased  inhibition  for plasmin.  Trypsin 
inhibition was different from plasmin inhibition, but could not be distinguished 
from chymotrypsin inhibition. Whatever is said about trypsin inhibition, there- 
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1.  Clinical Data and Plasmin Inhibition.--There were too few instances  of 
increased  plasmin  inhibition  (Fig.  1,  Paper II)  to permit  any correlation  to 
be made with  clinical  data.  It was interesting  to note that  the patient  with 
the highest level of plasmin inhibition maintained  the same level on repeated 
determinations  during a  1 year period.  The condition for which he had been 
admitted  (tuberculosis)  gradually improved during the period of observation, 
TABLE I 
Inhibition of Trypsin by Sera of Patients with Neoplastic Diseases 
The 3 patients with Hodgkin's disease, the 2 patients  with chronic lymphatic  leukemia, 
and the 2 patients  with lymphosarcoma that showed increased inhibition had received x-ray 
therapy prior to admission. The level of inhibition  of all other cases was determined before 
any treatment was~given. 
No. of  subjects  No. showing  No. showing 
normal  increased  Type of neoplastic  disease  observed  inhibition  inhibition 
Cancer of the large bowel and rectum 
Cancer of the stomach 
Cancer of the tongue 
Cancer of the esophagus 
Hodgkin's disease 
Chronic lymphatic leukemia 
5 
4 
4 
1 
3 
2 
Lymphosarcoma 
Multiple myeloma 
Chronic myeloid leukemia 
Acute lymphatic leukemia 
Cancer of the breast 
Cancer of the prostate 
Cancer of the lung 
Cancer of the cervix 
Abdominal carcinomatosis 
Cancer of the bladder 
Cancer of the liver 
Basal cell carcinoma 
Fibrosarcoma 
Seminoma 
Totals.. 
3 
2 
1 
1 
10 
5 
5 
5 
3 
2 
2 
2 
1 
1 
59 
1  2 
1  1 
1  0 
1  0 
9  1 
2  3 
0  5 
2  3 
•  0  3 
1  1 
1  1 
2  0 
0  1 
0  1 
28  41 
2.  Clinical Data and  Trypsin Inhibition.--Of  the  patients  with  neoplastic 
disease  (Fig. 2, Paper II), 55 per cent showed increased trypsin inhibition.  In 
Table I  are listed  the types of neoplastic diseases  studied  and the number of 
each type which showed normal or increased  trypsin inhibition.  By correlat- 
ing the level of trypsin inhibition with the histological appearance of the vari- 
ous tumors  (obtained by biopsy, operative  removal,  or autopsy)  it appeared 
that  increased  trypsin  inhibition  was  associated  chiefly with  processes  that 608  INHIBITION OF PROTEOLYTIC  ENZYMES  BY SERUM. III 
brought about cellular destruction. The presence of increased trypsin inhibition 
and the degree of increase were more closely related to the amount of dis- 
integration and inflammatory reaction in the tumor than to other factors such 
as type, size, or duration of the tumor. Those tumors most prone to ulceration 
and  secondary  infection  showed  a  high  correlation  with  increased  trypsin 
inhibition (e.g., cancer of the lung, tongue, stomach, large bowel, and rectum), 
while cancer of the breast, although metastic in 8 of the 10 patients studied, 
did not. 
In  the patients with  lymphoma or leukemia,  increased trypsin inhibition 
was more closely related to the recentness of x-ray radiation that the patients 
TABLE H 
Inhibition  of Trypsin by Sera of Patients with Acute Diseases 
The level of inhibition was determined on the day of admission. The 2 patients with lobar 
pneumonia that showed normal inhibition and the 2 patients with myocardial infarction 
that showed normal inhibition had had symptoms  for less than 2 days. All other patients had 
had symptoms for more than 2 days. 
Disease process  No. of subjects  normalN°"  showinginhibi. NO.increasedShOwing 
observed  tion  inhibition 
Lobar pneumonia 
Primary atypical  (virus)  pneumonia 
Coronary occlusion 
Acute rheumatic fever 
Osteomyelltis 
Bronchiectasis 
Virus  hepatitis 
Infectious  mononucleosis 
Cellulitis  of  the  hand 
Lung abscess 
Totals ....................................  28  9  19 
had received than to the extent of the disease. Patients with incipient or ad- 
vanced lymphomatous or leukemic conditions had normal trypsin inhibition' 
ff no x-ray treatment had been given beforehand, while patients who had re- 
ceived x-ray treatment within 2 weeks of the measurement had elevated trypsin 
inhibition regardless of the stage of the disease. 
The types of acute diseases  studied and  the number of each type showing 
normal or increased trypsin inhibition are listed in Table II. All the patients 
studied were admitted to the hospital after symptoms had been present for 
2 days or more, with the exception of 2 patients with pneumonia and 2 patients 
with myocardial infarction. 68 per cent of the patients had increased inhibition. 
The degree of increase was greatest with acute bacterial infection, particularly 
if the disease was well established at the time of measurement. N.  RAPHAEL  SHULMAN  609 
The 2 patients with lobar pneumonia who were seen when symptoms had 
been present for less than 2 days were found to have normal trypsin inhibition, 
in contrast to other patients with lobar pneumonia who were seen later in the 
course of the disease. The changes in trypsin inhibition were followed in these 
2 early cases of pneumonia, in another case of lobar pneumonia of 3 days' dura- 
tion, and in 2 cases of myocardial infarction of recent occurrence. In the pa- 
tients with pneumonia (Table III), trypsin inhibition rose rapidly during the 
first few days in spite of effective penicillin treatment, reached a peak at ap- 
proximately the 4th to the 6th day of illness, and then gradually declined to 
normal in the subsequent week or two. In the period of decline, trypsin inhibi- 
tion was still significantly elevated while the patient showed no signs or syrup- 
TABLE III 
Inhibition of Trypsin by Sera of Pativngs migh Lobar Pneumonia During fhe Course of the Disease 
Description in text. Inhibition expressed as micrograms of trypsin inhibited by 4.2 ×  10  -4 
ml. of serum. All patients were treated with penicillin. 
Duration of illness 
days 
1 
2 
3 
4 
5 
6 
7 
10 
14 
17 
Case I 
1.25 
1.20 
1.57 
2.30 
1.98 
1.50 
1.17 
Trypsin inhibited 
Case 2 
,y 
1.30 
2.04 
2.53 
2.83 
2.00 
1.40 
1.32 
Case 3 
V 
1.98 
2.50 
3.00 
2.70 
2.00 
1.86 
1.47 
toms of disease. In the cases of myocardial infarction (Table IV), trypsin in- 
hibition remained normal for at  least 5  days after onset of the illness,  rose 
gradually to a  peak near the  10th day of illness,  then gradually declined to 
normal. Thus, inhibition could be normal in the early stages of an acute proc- 
ess and elevated when other manifestations of the disease had cleared. Simi- 
lar observations were made by Jobling et al. (6) in a  study of the changes in 
trypsin inhibition during the course of pneumonia. 
In  patients  with  acute  diseases  the  development of increased  trypsin  in- 
hibition appeared  to be related to  tissue destruction.  Inhibition was higher 
when  tissue  involvement was  more extensive. An  uncomplicated process of 
tissue necrosis such as myocardial infarction was associated with significant 
and prolonged increases in trypsin inhibition. The stage of the disease at which 
trypsin inhibition increased also suggested that cellular destruction preceded 
the  development of  increased  inhibition.  This  was  especially noticeable  in 610  INHIBITION  OF  PROTEOLYTIC  ENZYMES  BY  SERUM.  HI 
cases of myocardial infarction, in which the elapsed time before increased in- 
hibition developed was  about the  time usually required for gross tissue de- 
generation to become evident. 
A large percentage of the patients with tuberculosis (Fig. 2, Paper II) showed 
increased trypsin inhibition, but it was impossible to associate the extent of a 
tuberculous process with  the  amount  of inhibition.  Although  all  the  cases 
studied  were  considered  to  have  active  tuberculosis,  diagnostic  limitations 
prevented a  critical appraisal  of the activity of the disease in each case. In 
this small series there was no correlation between the level of trypsin inhibition 
and such objective criteria of activity as the amount of cavitation or the value 
of the Gaflky count. 
TABLE IV 
Inhibition of Trypsin by Sera of Patients with Myocardial Infarction Compared to the 
Sedimentation Rate during the Course of the Disease 
Inhibition expressed as micrograms of trypsin inhibited by 4.2  X  10  -4 ml. of serum. 
Sedimentation rate corrected for hematocrit value. 
Duration of illness 
days 
1 
3 
5 
7 
lO 
14 
21 
28 
Trypsin 
inhibited 
,y 
1.25 
1.00 
1.90 
3.20 
3.01 
1.92 
1.30 
Sedimentation 
rate 
Trypsin 
inhibited 
Case 1 
•va./hr. 
8 
12 
3O 
55 
42 
28 
12 
0.74 
0.85 
2.00 
2.78 
2.53 
2.04 
1.04 
Case2 
Sedimentation 
rate 
ram./kv. 
10 
6 
3o 
45 
48 
32 
13 
Correlation of Laboratory Findings with Abnormal Proteolytic Inhibition 
1.  Laboratory Data and Plasmin Inhibition.--The few instances of increased 
plasmin inhibition did not permit any correlation to be made with laboratory 
data. 
2.  Laboratory Data and Trypsin Inhibition.--All types of cases were analyzed 
together  in  an  attempt  to  demonstrate  a  possible  relationship between  in- 
creased trypsin inhibition and abnormalities in some usual laboratory meas- 
urement. 
There was no consistent relationship between normal and abnormal trypsin 
inhibition  and  normal  or  abnormal  plasma  proteins,  blood  urea  nitrogen, 
alkaline phosphatase, liver function tests, or electrolyte balance. As has been 
shown  previously  (6,  7),  there  was  also  no  consistent relationship between 
changes in trypsin inhibition and changes in the white count or temperature. N.  I~APHAEL  SHULMAN  611 
A  direct relationship was found, however, between one simple laboratory 
procedure and increased trypsin inhibition. 100 per cent of the cases showing a 
significantly elevated sedimentation rate had increased trypsin inhibition, and 
none of the cases with a normal sedimentation rate had increased trypsin in- 
hibition. The correlation was based on sedimentation rate determinations done 
in 31 of the 117 cases studied, excluding the patients with myocardial infarction. 
The relationship between trypsin inhibition and the sedimentation rate was 
particularly striking in the cases of myocardial infarction (Table IV). 
I  RELATIONSHIP 
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800  • 
600 
400 
200 
! 
I0 
•  O O 
range of 
normal  values 
g  i  , 
TRYPSIN INHIBI:rED  1.0  2.0  5.0 
(gamma) 
FIG. 1. Comparison  of the level of inhibition of trypsin with the fibrinogen  concentration 
in 20 blood samples. Description in text. Inhibition of trypsin expressed as micrograms in. 
hibited by 4.2 X  10  ~  ml. of serum. Fibrinogen expressed as nag. per 100 ml. 
3. Fibrinogen Concentration and Trypsin Inkibition.--Since elevation of the 
sedimentation rate has been shown to be dependent primarily upon elevation 
of fibrinogen concentration (8), 20 additional patients were studied to compare 
the level of trypsin inhibition with the fibrinogen concentration. The 20 pa- 
tients  had  undergone  extensive surgery  for  various  neoplastic  diseases;  all 
were 5 to 7 days postoperative and had had febrile courses. Results of the com- 
parison are shown in Fig.  1.  There was close correlation between fibrinogen 
concentration and the level of trypsin inhibition. In every instance in which 
fibrinogen concentration was increased, trypsin inhibition was also increased 
(within experimental error), and  vice versa. Moreover, the increases in both 
trypsin inhibition and fibrinogen concentration were quantitatively similar. 612  INHIBITION O~'  PROTEOLYTIC ENZYMES BY SERUM. IH 
Correlation between Experimentally  Produced Increases in  Trypsin Inkibition 
and Fibrinogen Concentration 
Ham and Curtis (9) found that intravenous injections of typhoid vaccine 
would produce prolonged elevation of the fibrinogen level  in human beings. 
In view of the close correlation between fibrinogen concentration and the level 
of trypsin inhibition demonstrated above, the effects of intravenous typhoid 
vaccine on serum proteolytic inhibition  and  fibrinogen  concentration were 
compared. 
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FIG. 2.  The  effect of intravenous  typhoid  vaccine on fibrinogen concentration  and  the 
level of inhibition of trypsin and plasmin.  Subject, J. M., 43 year old male. Description in 
text. Each cc. of typhoid vaccine contained 100  X  l0  s killed bacilli. Time of injection indi- 
cated by arrow. Inhibition of trypsin expressed as micrograms inhibited by 4.2  ×  l0  -4 ml. 
of serum.  Inhibition of plasmin  expressed  as micrograms inhibited by  1.65 ×  i0--s ml. of 
serum. Fibrinogen expressed as rag. per 100 ml. 
The subjects used were patients  on the Medical Service of the James Ewing Hospital. 
The first subject, J. M., was a morphine addict, taking ~  grain of morphine every 4 hours; 
he was admitted  on pretext and no medical abnormality was found. The other 3  subjects 
each had had  a  meningioma removed 6  months or more prior to admission; they were re- 
ceiving physical  therapy  for  paralytic  contractures.  All  subjects  were  otherwise healthy, 
normal adults. 
Preliminary measurements were made on each subject prior to injecting typhoid vaccine. 
After the injection, blood samples were taken every 45to 90 minutes in the first 5 hours (the 
immediate postinjection period). In the next 8 hours, 2 or 3 more samples were taken, and 
after that,  1 sample was taken every 1 to 3  days for the remaining period of observation. 
Plasma and serum samples were immediately frozen and stored at  -15°C. Each procedure 
was carried out on all samples from one experiment at the same time. Frozen samples were 
thawed just prior to their use. 
The effects of intravenous typhoid vaccine on fibrinogen concentration and 
the level of trypsin and plasmin inhibition are shown in Figs. 2 to 6. Of chief 400 
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FIG. 3.  The  effect of intravenous  typhoid  vaccine on  fibrinogen concentration  and  the 
level of inhibition of trypsin and  plasmin.  Continuation of observations on J.  M., 43  year 
old male, from the 21st  day. Conditions as in Fig. 2. 
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FIG. 4.  The effect of intravenous  typhoid  vaccine on  fibrinogen concentration  and  the 
level of inhibition of trypsin and plasmin. Subject, L. N., 45 year old male. Conditions as in 
Fig. 2. 
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Fig. S.  The  effect of intravenous  typhoid  vaccine on  fibrinogen concentration  and  the 
level of inhibition of trypsin and plasmin. Subject, R. C., 48 year old female. Conditions as 
in Fig. 2. 
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FIG. 6.  The  effect of intravenous  typhoid  vaccine on  fibrinogen concentration  and  the 
level of inhibition of trypsin and plasmin. Subject, L. G., 40 year old female. Conditions as 
in Fig. 2. 
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interest at present are the changes in the measurements that occurred begin- 
ning 1 day after the vaccine injection. When small amounts of vaccine were 
used (Fig. 2), there was no significant alteration in any of the measurements in 
the period beginning 1 day after injection. With the larger amounts of vaccine 
(Figs. 3 to 6), an increase in fibrinogen concentration above the baseline value 
was  evident  1  day  later.  The  maximum  value  of  fibrinogen  concentration 
was reached within 24 to  72 hours after injection. The subsequent  decrease 
to the baseline level was more gradual,  requiring 6  to  12  days.  Changes in 
trypsin inhibition (beginning 1 day after injection) were parallel with those of 
the fibrinogen concentration. Both the temporal and the quantitative aspects 
of the changes in these two measurements were alike. Serum proteolytic in- 
hibition was specifically elevated for trypsin, ~ince at no time did the inhibi- 
tion for plasmin rise above normal. 
In the immediate  postinjection period there was  an  inconstant  decrease in 
fibrinogen as well as in inhibition of trypsin and plasmin.  Whenever such a 
decrease in these measurements occurred, an active proteolytic enzyme was 
present in the blood samples taken shortly after the injection. This phenomenon 
and  other  phenomena  occurring  in  the  immediate  postinjection  period  are 
being  investigated  at  present  to determine their possible relationship  to the 
subsequent  development of increased  trypsin  inhibition and  fibrinogen con- 
centration. 
DISCUSSION 
Previous workers demonstrated that trypsin inhibition  by serum is increased in a 
variety of diseases;  e.g.,  in  acute bacterial infections  such  as pneumonia  (1)  and 
typhoid fever (7),  in  chronic diseases  such  as  tuberculosis,  rheumatic fever, and 
nephritis  (7,  11), in  hyperthyroidism (7),  and  in  all  forms  of neoplastic  diseases 
(10, 11). It was pointed out by several early investigators  (7, 12, 13) that a factor which 
the various  disease states have in common is tissue  destruction of some type, and 
they therefore suggested  that tissue  destruction plays a role in the development of 
increased  trypsin inhibition.  More recently Raab  (14) came to the same conclusion 
after finding that the increase  of trypsin inhibition  in patients with cancer was re- 
lated chiefly to the presence of tissue disintegration  in the tumor. 
In the present study a clinical analysis was made of the relationship of the 
level of trypsin inhibition to the stage of the disease process,  to histological 
changes in tissues,  and to some special instances of tissue destruction (myo- 
cardial infarction and x-radiation) as well as to the various types of diseases. 
This analysis provided additional evidence that the development of increased 
trypsin inhibition is related  to tissue destruction. 
The clinical evidence for the relationship between increased trypsin inhibi- 
tion and tissue destruction is supported by the finding that increased trypsin 
inhibition  is associated with an  increase in  the fibrinogen concentration  (or 
sedimentation rate).  It h~s  been  shown  by numerous  studies  (reviewed by 
Ham  and  Curtis  (9))  that  the  fibrinogen  concentration  (or  sedimentation 616  IN]KIBITION OF PROTEOLYTIC ENZYMES BY SERUIK. HI 
rate)  is increased by processes of tissue destruction, whether bacterial, neo- 
plastic, traumatic, or chemical in origin. 
A  close  relationship  was  found between  elevated  trypsin  inhibition and 
increased sedimentation rate. In the cases of myocardial infarction that were 
studied, changes in these two measurements paralleled  each  other through- 
out the course of the disease. In 20 patients, increases in the level of trypsin 
inhibition and the fibrinogen concentration were found to be quantitatively 
alike. By the injection of typhoid vaccine, it was found that not only were 
increases  in  trypsin inhibition and fibrinogen quantitatively alike, but also 
the time of changes in the two measurements  was  the  same. These  several 
findings substantiate each other. 
Data that have been obtainecl concerning the circumstances associated with 
variations in trypsin inhibition have never been compared with data obtained 
concerning the variation in fibrinogen concentration  (or sedimentation rate). 
A  comparison of these two separate  sets of data bears out the experimental 
observations above that trypsin inhibition and fibrinogen level vary together. 
In this comparison the review of the literature by Ham and Curtis (9) is used 
as the chief source of information on the variation in fibrinogen level. 
The normal  variation  in trypsin inhibition and fibrinogen concentration is 
similar. In the group of normal individuals studied, the variation in trypsin 
inhibition is 64 per cent of the mean and the variation in fibrinogen concentra- 
tion is reported to be 50 per cent of the mean (9). It was found that, in a single 
individual during health, trypsin inhibition shows a 28 per cent variation from 
the mean and the fibrinogen concentration is reported to show an 18 per cent 
variation in one individual over a comparable period of time (9). Variation in 
the two measurements in a group of individuals and in a single individual are 
even more alike than these values would indicate, for the experimental error 
in determining trypsin inhibition was somewhat greater than the error in de- 
termining fibrinogen. For both measurements the range of variation in a series 
of normal subjects is greater  than the variation in any one subject during 
health. 
In the present work it was found that trypsin inhibition is not affected by 
recent food ingestion. This finding is in agreement with the study by Jobling 
et al.  (15) on the effect of food ingestion on trypsin inhibition in dogs. The 
fibrinogen concentration also is not influenced by recent food ingestion (9). 
It was found by Rosenthal (16) that long periods of starvation decreased the 
level of trypsin inhibition in rabbits and it is known that the level of fibrinogen 
in human beings is decreased in association with nutritional deficiency (9). 
The pathological variation  in trypsin inhibition and fibrinogen concentration 
is similar. All the disease states which have been shown to be associated with 
increased trypsin inhibition are also associated with elevation of the fibrinogen 
concentration (or sedimentation rate). It has been shown that trypsin inhibi- 
tion could be normal in the early stages of an acute process and elevated when N. RAPHAEL  SHUL~[AN  617 
other manifestations of the disease had cleared. Changes in fibrinogen concen- 
tration in disease occur in a similar way (9). It was also shown above by simul- 
taneous determination of the two measurements (Figs. 3  to 6)  that changes 
in each are parallel following an injection of typhoid vaccine. The increase in 
trypsin inhibition in the various diseases rarely exceeds 3  times the normal 
value, and increases in fibrinogen concentration in disease are of the same order 
of magnitude. 
Trypsin inhibition was found, in the present study as well as in previous 
studies (6, 7), to vary independently of temperature, white count, plasma pro- 
tein concentration, and other chemical determinations on the blood. Fibrinogen 
concentration likewise varies independently of these various measurements (9). 
Pregnancy is  the  only  "normal" physiological condition associated  with 
increased fibrinogen concentration.  Similarly pregnancy is  the  only normal 
circumstance in which trypsin inhibition is increased. When data on changes 
in trypsin inhibition during pregnancy (17)  are  compared with the data on 
changes in  fibrinogen concentration during pregnancy (18),  it  is  seen  that 
increases in trypsin inhibition occur at the same stage of pregnancy and persist 
for the same length of time after parturition as do increases in fibrinogen con- 
centration. 
Diagnostically, an abnormal elevation of trypsin inhibition has  the same 
significance as an elevated fibrinogen concentration. It therefore has the same 
significance as an elevation of the sedimentation rate ff increased sedimentation 
is due to changes in fibrinogen concentration and not to other factors such as 
abnormal plasma globulins,  lipemia,  or changes in  erythrocyte size.  In  the 
absence of pregnancy, elevated trypsin inhibition affords laboratory evidence 
for an organic disease process which may be present at the time of observation 
or which may have terminated several days or weeks before. As in the case of 
a slight rise in fibrinogen, a  slight increase in trypsin inhibition above the in- 
dividual's norm may not result in a level of trypsin inhibition beyond statisti- 
cally normal limits. Such a moderate response in trypsin inhibition would not 
be detected without previous knowledge of the level during health, but never- 
theless may represent a trypsin inhibition response of pathological significance 
for the individual. Elevation of trypsin inhibition is a non-specific indication 
of disease and tissue destruction; there is no apparent value in using the meas- 
urement of trypsin inhibition as a specific diagnostic test. 
The factors associated with changes in plasmin inhibition and the physio- 
logical significance of increased plasmin inhibition are as yet unknown. 
The question of why trypsin inhibition and fibrinogen concentration vary 
together remains to be answered. Certainly fibrinogen itself does not inhibit 
trypsin. It is known that plasma and serum inhibit trypsin to the same extent, 
and in Paper I  it was shown that tryptic digestion of fibrinogen was increased 
by increasing the concentration of the fibrinogen substrate.  In the typhoid 
vaccine experiments there was no indication as to whether one measurement 618  INHIBITION  OF  PROTEOLYTIC  ENZYMES  BY  SERUM.  III 
changed before the  other. With  the  available data,  no definite conclusions 
can be drawn as to whether an increase in one substance is the cause of an 
increase in the other substance or whether increases in both are fortuitously 
related. Further work is indicated to determine the significance of the associa- 
tion between changes in fibrinogen concentration and trypsin inhibition. 
SUMMARY 
Variation in the inhibition of trypsin, chymotrypsin, and plasmin by serum 
was studied in 65  normal individuals and in  117  patients with a  variety of 
diseases. 
It was shown that elevated inhibition for trypsin and chymotrypsin is asso- 
ciated with disease processes that bring about cellular destruction. 
Changes in  the  inhibition of trypsin and  chymotrypsin were  closely cor- 
related  with  changes  in  the  erythrocyte sedimentation rate  and  fibrinogen 
concentration that occur in association with disease. 
Intravenous typhoid vaccine was found to produce parallel changes in the 
inhibition of trypsin and chymotrypsin and in the fibrinogen concentration in 
human beings. 
It was  concluded that  the  diagnostic significance of increased trypsin or 
chymotrypsin inhibition is the same as that of increased fibrinogen concentra- 
tion; it is a  common, non-specific response to a variety of pathological condi- 
tions and has no value as a  specific  diagnostic test. 
Increased plasmin inhibition occurred too infrequently to permit detailed 
study. 
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